Health Care & Life Sciences » Pharmaceuticals | Choong Ang Vaccine Laboratory

Choong Ang Vaccine Laboratory | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
24,349
29,609
34,605
37,900
31,867
Cost of Goods Sold (COGS) incl. D&A
12,516
17,344
22,795
21,366
17,089
Gross Income
11,833
12,264
11,810
16,534
14,778
SG&A Expense
6,734
6,727
8,177
9,547
9,231
EBIT
5,099
5,537
3,633
6,987
5,547
Unusual Expense
-
-
-
48
-
Non Operating Income/Expense
41
508
35
250
240
Interest Expense
88
79
75
55
61
Pretax Income
5,241
5,113
3,651
7,290
5,359
Income Tax
791
828
397
1,080
779
Consolidated Net Income
4,450
4,284
3,254
6,209
4,579
Net Income
4,450
4,284
3,254
6,209
4,579
Net Income After Extraordinaries
4,450
4,284
3,254
6,209
4,579
Net Income Available to Common
4,450
4,284
3,254
6,209
4,579
EPS (Basic)
491.84
473.23
359.98
685.98
506.40
Basic Shares Outstanding
9
9
9
9
9
EPS (Diluted)
491.73
473.49
359.64
686.19
506.08
Diluted Shares Outstanding
9
9
9
9
9
EBITDA
8,501
8,616
7,277
9,975
8,976
Non-Operating Interest Income
188
162
128
155
113

About Choong Ang Vaccine Laboratory

View Profile
Address
1476-37 Yuseong-daero
Daejeon DE 34055
Korea, Republic Of
Employees -
Website http://www.cavac.co.kr
Updated 09/14/2018
Choong Ang Vaccine Laboratory Co., Ltd. engages in the provision of animal health solutions and biologicals. Its main products include vaccines for swine, poultry, dog, cattle, cat, rabbit, and fish, rapid diagnostic kits and, diagnostic kits. The company was founded on December 6, 1968 and is headquartered in Daejeon, South Korea.